Strong India biopharma industry triggers pay hikes

With biopharma booming in India, companies say they're paying U.S. rates for top talent, with plenty of added bonuses on flexible working schedules and travel to and from the U.S. Suven Life Sciences says that their R&D payroll has rocketed up 87 percent in the past year as the company competes for top scientific talent. The most competitive salaries are going to the research chiefs.

- read the report from The Business Standard

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.